Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation (original) (raw)
Endocardial Notch1 activation causes heart dysmorphogenesis and ectopic target gene expression. To investigate whether ectopic Notch1 activation in the heart was sufficient to drive EMT, we activated Notch1 in the endocardium, myocardium, or both tissues. We used the conditional N1ICD transgenic line R26N1ICD, which upon Cre activation expresses the Notch1 intracellular domain (amino acids 1749–2293) and nuclear-localized enhanced GFP (20). R26N1ICD mice (from now on, N1ICD) were crossed with the endothelium/endocardium-specific Tie2-Cre driver line (ref. 21 and Supplemental Figure 1A; supplemental material available online with this article; doi:10.1172/JCI42666DS1). At E9.5, Tie2-Cre;N1ICD embryos were smaller than WT littermates and showed pericardial distension and enlarged LV and atrium (Figure 1A). EGFP expression delineated the endocardium, indicating N1ICD expression (Figure 1B). Scanning electron microscopy revealed AVC mesenchymal cells invading the cushion region in E9.5 WT embryos (Figure 1, C and E). Transgenic littermates had relatively fewer mesenchymal cells in AVC cushion tissue (Figure 1, D and F), probably due to a slight developmental delay. H&E-stained sections were consistent with these findings (Supplemental Figure 1, B–E) and revealed poorly formed trabeculae in E9.5 transgenic embryos (Supplemental Figure 1, F and G).
E9.5 Tie2-Cre;N1ICD mice ectopically express mesenchyme genes in chamber endocardium. (A) WT and Tie2-Cre;N1ICD embryos. Dotted lines indicate C and D section planes. (B) Endocardial EGFP expression in a Tie2-Cre;N1ICD embryo. at, atrium. (C and D) SEM images of longitudinal WT (C) and Tie2-Cre;N1ICD (D) heart sections. (E and F) Details of AVC in WT (E) and Tie2-Cre;N1ICD hearts (F). Arrows, mesenchymal cells. (G) Semiquantitative RT-PCR analysis in hearts. (H) Snail1 Western blot. (I–P) WISH, heart details. Arrowheads, AVC myocardium; thin arrows, AVC endocardium; thick arrows, ventricular endocardium. (I) Tgfb2 expression in WT AVC myocardium and endocardium (bracket). (J) Normal Tgfb2 expression in AVC and ectopic expression in ventricular endocardium of Tie2-Cre;N1ICD embryos. (K and L) WT mice express Snail1 in AVC endocardium and mesenchyme (K); Tie2-Cre;N1ICD embryos show ectopic expression in ventricular endocardium (L). Tie2-Cre;N1ICD hearts also show ectopic ventricular expression of Snail2 (N) and Twist2 (P). (Q–V) Snail1 expression (red) in E9.5 heart. Nuclei are DAPI counterstained (blue). (Q) General view of an E9.5 WT heart. (S) Detail of AVC region. Arrows, nuclear Snail1 in endocardial and mesenchyme cells. (U) Detail of LV region with an ENC weakly expressing Snail1 (arrow). (R) General view of Tie2-Cre;N1ICD heart. (T) Detail of AVC. Arrows, nuclear Snail1 staining in endocardium and mesenchyme. (V) Ectopic Snail1 staining in ventricular endocardium. Scale bars: 100 μm (A and B); 125 μm (C and D); 20 μm (E and F); 10 μm (I–P); 30 μm (Q and R); 20 μm (S–V).
Whole-mount in situ hybridization (WISH) and RT-PCR in Tie2-Cre;N1ICD embryos showed that endocardial expression of N1ICD and its targets Hey1 and Hey2 (22), Heyl (17), Delta-like 4 (23), Nrarp (24), and c-myc (25) was increased and expanded from the AVC to the ventricles (Supplemental Figure 1, H–T), indicating increased Notch activity throughout the endocardium. CD31/PECAM and MLC2v expression, indicative of early endocardial and myocardial differentiation, were normal (Supplemental Figure 2 and data not shown). The expression domains of Anf (26) and Chisel (27) in the AVC were less well defined in Tie2-Cre;N1ICD embryos compared with WT animals (Supplemental Figure 2, A and B), though their expression levels were unaffected (Supplemental Figure 2K and data not shown). Irx5, normally expressed in ventricular endocardium (ref. 28 and Supplemental Figure 2C), was strongly reduced in Tie2-Cre;N1ICD embryos (Supplemental Figure 2, D and K), suggesting loss of chamber identity.
The expression of endothelial identity markers was examined, given that the Tie2-Cre driver is active in the vascular endothelium as well (21). Tie2-Cre;N1ICD embryos ectopically expressed the Dll4 and Efnb2 markers in veins (Supplemental Figure 3, A–D), while expression of the venous marker Ephb4 was reduced (Supplemental Figure 3, E and F), suggesting that the vascular endothelium of transgenic embryos had lost its venous identity. Tie2-Cre;N1ICD embryos died at E11.0, probably as a consequence of defective vascular and hematopoietic development (P. Melgar and J.L. de la Pompa, unpublished observations).
Activation of a mesenchyme gene expression program characteristic of AVC in the ventricular endocardium of Tie2-Cre;N1ICD embryos. Bmp2 is expressed in AVC myocardium at E9.5 and triggers the EMT of adjacent ENCs (9). Bmp2 expression was slightly weaker at E9.5 and was unaffected in E10.5 Tie2-Cre;N1ICD embryos (Supplemental Figure 2, E, F, and K). Tgf-β2, which acts downstream of Bmp2 (9) is transcribed in AVC myocardium at E9.5 and at lower levels in AVC endocardium and mesenchyme (ref. 8, Figure 1I, and Supplemental Figure 5A). Tgfb2 showed slightly weaker expression in Tie2-Cre;N1ICD AVC and was ectopically expressed in ventricular endocardium (Figure 1J and Supplemental Figure 5B). RT-PCR revealed normal Tgfb2 expression, probably because of ectopic expression in the ventricles (Figure 1G). Snail1, expressed in response to Notch (12) and TGF-β2 (29), was detected in AVC endocardium and mesenchymal cells of WT embryos (Figure 1K and Supplemental Figure 5C). In transgenic embryos, Snail1 transcription was extended to the ventricular endocardium (Figure 1L and Supplemental Figure 5D) and increased (Figure 1G). Ectopic Snail1 expression in ventricles was confirmed by Western blot (Figure 1H). Immunostaining showed Snail1 expression in the nuclei of WT and Tie2-Cre;N1ICD AVC endocardial and mesenchyme cells (Figure 1, Q–T). Transgenic embryos displayed ectopic nuclear Snail1 expression in ventricular ENCs (Figure 1, U and V). Sox9, a Tgf-β2 target in mesenchymal cells implicated in endocardial cushion cell differentiation (30), was transcribed in AVC endocardium and mesenchyme (Supplemental Figure 4A) and its expression was increased and expanded to the ventricles in transgenic embryos (Supplemental Figure 4, B and I).
Affymetrix microarray analysis to identify additional genes differentially expressed in Tie2-Cre;N1ICD E9.5 hearts uncovered 516 genes, 66 of which were downregulated and 450 of which were upregulated (Supplemental Excel file). Many of the upregulated genes were associated with EMT initiation, mesenchymal phenotype maintenance, cell migration, invasion, adhesion, and collagen deposition (Supplemental Table 1). These included Snail2, Twist2, Bmp6, and the Bmp receptor genes Alk3 and Alk6 (Supplemental Table 1), all of which are essential for EMT in different cellular contexts (31–33). Snail2, like Snail1, is required for Notch-induced EMT (31), and its expression was expanded in Tie2-Cre;N1ICD embryos from AVC endocardium and mesenchyme to the ventricular endocardium (Figure 1, M and N, and Supplemental Figure 5, E and F) and increased (Figure 1G). Twist1 is required downstream of Bmp2 during AVC EMT (10), but Twist1 expression was not altered in the microarray (Supplemental Excel file) or by WISH or RT-PCR (Supplemental Figure 2, G, H, and K), suggesting that Bmp2-dependent signaling in Tie2-Cre;N1ICD embryos was unaltered. In contrast, Twist2 expression was expanded from AVC to ventricles (Figure 1, O and P, and Supplemental Figure 5, G and H) and increased (Figure 1G), but the late EMT marker Has2 (34) was unaltered (Supplemental Figure 2, I–K). Similarly, Bmp6, normally expressed in AVC endocardium (Supplemental Figure 4E) and required for cushion morphogenesis (33), was ectopically expressed in the ventricle of transgenic embryos (Supplemental Figure 4, F and I). Expression of the chemokine receptor gene Cxcr4, involved in cell migration and metastasis (35), was increased in transgenic embryos (Supplemental Table 1 and Supplemental Figure 4I) and expanded from AVC endocardium to ventricular endocardium (Supplemental Figure 4, G and H). A further 12 genes involved in EMT, cell migration, and invasion were significantly increased in transgenic embryos (Supplemental Table 1), and upregulation of the Notch pathway genes detected by WISH and RT-PCR (Supplemental Figure 1, H–T) was also confirmed. Thus, Tie2-Cre;N1ICD embryos show the expansion of mesenchymal gene expression from AVC to ventricles. Moreover, expression of the chamber marker Hand2 was strongly reduced (Supplemental Table 1), confirming the loss of ventricular chamber identity in Tie2-Cre;N1ICD embryos.
Tie2-Cre;N1ICD ventricular explants undergo Tgf-β2 and Snail1-dependent EMT. Culture of AVC explants on a type I collagen gel lattice is an excellent functional assay to evaluate EMT (36). To quantify differences between WT and transgenic explants, we determined the “transformation index” (TI) in 2 and 3 dimensions. 2D TI is the fraction of ENCs able to detach and migrate on the gel surface without invading the collagen matrix. 3D TI is the fraction able to invade the gel. After 72 hours, E9.5 WT AVC explants produced a halo of mesenchymal cells around the myocardium (Supplemental Figure 6A), with mesenchymal cells invading the collagen depths (Supplemental Figure 6A and Supplemental Video 1). E9.5 Tie2-Cre;N1ICD explants also produced invasive mesenchymal cells (Supplemental Figure 6B and Supplemental Video 1), but while 3D TI was similar for both genotypes (3D = 0.1), 2D TI was 3-fold higher in transgenic explants (0.35 vs. 0.15; Supplemental Figure 6C). Expression of EMT-inducing molecules in WT and transgenic ENCs was similar. Similar to the situation in vivo, Hey1 was ectopically expressed and upregulated in transgenic ENCs, together with Hey2, Heyl, and the mesenchymal marker Vimentin (Supplemental Figure 6D).
To determine whether ectopic Notch1 activity conferred transforming ability on ventricular tissue, we performed explant cultures with the distal tip of the LV. WT explants generated an endocardial monolayer surrounding the myocardium (Figure 2A), and ENCs grew as a coherent epithelium on the collagen surface (Figure 2A and Supplemental Video 2). In contrast, in Tie2-Cre;N1ICD explants, ENCs migrated over the gel and had a mesenchymal phenotype revealed by α-SMA staining (Figure 2B). These transformed cells did not invade the collagen matrix (Figure 2B and Supplemental Video 2), but their migratory ability was reflected in a sharply increased 2D TI (0.9 vs. 0.1; Figure 2C). Unlike WT cells, ENCs of transgenic explants expressed the mesenchymal markers Snail1, Snail2, Tgfb2, Vimentin, Periostin (37), and very low levels of Has2 (ref. 34 and Figure 2D) and Collagen. Twist1 was unaffected, consistent with the in vivo data (Figure 2D).
Tie2-Cre;N1ICD ventricular explants undergo Tgf-β2– and Snail1-mediated ectopic EMT. (A, E, and I) Details of WT explants. (B, F, J, M, and N) Details of Tie2-Cre;N1ICD explants. Full lateral views of explants are shown below panels A–N. Schematic of a full lateral view of explant is shown at the bottom of panel A. e, endocardium (red); m, myocardium (green). All explants were stained with phalloidin-FITC (green), anti–α-SMA–Cy3 (red), and DAPI (blue). Arrows mark ENCs. (C, G, K, and O) Quantitative analysis of 2D and 3D TI. (D, H, L, and P) RT-PCR of explant endocardium. (A) WT. Arrow, ENCs growing as a monolayer. The lateral section shows ENC outgrowth on the collagen surface. (B) Tie2-Cre;N1ICD. Arrows, scattered ENCs that have undergone partial EMT. (C) 2D TI is increased in Tie2-Cre;N1ICD explants (P = 3.7 × 10–4). (D) Snail1, Snail2, Tgfb2, Vimentin, and Periostin expression is upregulated; Has2 is slightly increased and Twist1 appears unaffected. (E, F, and G) ENCs scatter without invading the collagen in TGF-β2–treated WT explants, and 2D TI is increased with respect to untreated WT ones (C; P = 1.8 × 10–7) and Tie2-Cre;N1ICD explants. (H) Increased Snail1, Snail2, and Tgfb2 expression. (I and K) ENCs of WT explants cultured with TGF-β2 and anti–TGF-β2 antibody grow as a monolayer and show reduced 2D TI with respect to TGF-β2–treated WT (G; P = 8.1 × 10–6). (J and K) Anti–TGF-β2 reduces ENC migration in Tie2-Cre;N1ICD explants, reflected in a reduced 2D TI (P = 2.3 × 10–5) and attenuated Snail1 expression (L). (M–O) Lentiviral-mediated shRNA Snail1 downregulation in transgenic explants reduces ENC migration with respect to GFP-transduced control explants (P = 3.3 × 10–8). LVi, lentivirus. (P) Expression of Snail2 and Tgfb2 is reduced. Scale bar: 50 μm. Results are expressed as mean + SD. ***P < 0.001.
The transformed ventricular ENCs of Tie2-Cre;N1ICD explants showed increased expression of Tgfb2 (Figure 2D), a key EMT inducer in AVC cells (8). Addition of TGF-β2 to WT ventricular explants mimicked the results with Tie2-Cre;N1ICD explants, inducing surface migration of ENCs but not invasion (Figure 2E). TGF-β2–treated WT ventricular explants had a 2D TI similar to untreated transgenic explants (0.75 vs. 0.9; Figure 2G) and expressed Snail1, Snail2, and Vimentin (Figure 2H). TGF-β2 had no additive effect on Tie2-Cre;N1ICD explants (Figure 2, F and G). A neutralizing anti–TGF-β2 antibody reverted the phenotype of Tie2-Cre;N1ICD and TGF-β2–treated WT ventricular explants to the endocardial monolayer seen in untreated WT explants (Figure 2, I–K), accompanied by reduced mesenchymal marker expression (Figure 2L).
During AVC EMT, Snail1, and Snail2 are key downstream effectors of Notch (12, 31) and TGF-β2 (38). To test the role of the Snail genes in the acquisition of the mesenchymal phenotype by ventricular ENCs, we transduced ventricular explant cells with Snail1 shRNAS. Two Snail1 shRNAs reduced the 2D TI of Tie2-Cre;N1ICD ventricular explants effectively (Figure 2, M–O). RT-PCR confirmed reduced Snail1 expression, though the reduction was greater for Snail2 (Figure 2P), consistent with the reported requirement of Snail1 for Snail2 expression (39). Tgfb2 expression was also reduced by Snail1 shRNAs (Figure 2P). This is consistent with the dose-dependent activation by Snail1 of a TGF-β2 reporter (data not shown), suggesting a functional link between Snail1 and Tgf-β2.
Ectopic endocardial N1ICD expression was examined in a stage-dependent manner using the tamoxifen-inducible line Cdh5(PAC)-CreERT2 (40). Recombination was induced from E9.5 to E10.5 and at E11.5, Cdh5(PAC)-CreERT2;N1ICD embryos showed hemorrhage in the heart and trunk region (Supplemental Figure 7, A and B) and increased N1ICD and Snail1 cardiac expression (Supplemental Figure 7C). Importantly, ENCs in ventricular trabeculae showed a fibroblastic, star-like morphology, contrasting with the flat ENCs in WT trabeculae (Supplemental Figure 7, D–I). Cdh5(PAC)-CreERT2;N1ICD ENCs transformed and migrated in ventricular explant assays (Supplemental Figure 7, J–L) but like Tie2-Cre;N1ICD ENCs were not invasive.
BMP2 confers invasivity on ventricular ENCs. Functional studies have shown that Bmp2 is a critical inducer of AVC EMT upstream of Tgf-β2 (9, 10). Bmp2 expression was unaffected in Tie2-Cre;N1ICD embryos (Supplemental Figure 2, E, F, and K), suggesting that Notch acts either downstream or independently of Bmp2 during cardiac EMT. BMP2 treatment of WT and Tie2-Cre;N1ICD ventricular explants produced invasive mesenchymal cells, significantly increasing 2D and 3D TI in WT explants and 3D TI in transgenic explants (Figure 3, A, B, D, and E, and Supplemental Video 3). Thus, BMP2 confers invasive ability to transformed ventricular ENCs. Expression of Snail1, Has2, and Periostin (but not Twist1) was upregulated in WT ventricular cells treated with BMP2 (Figure 3F), indicating that BMP2-treated WT ventricular explants acquire full mesenchymal features.
BMP2 induces ventricular explants to undergo Tgf-β2–, Notch-, and Snail1-mediated invasive EMT. All explants were triple stained as in Figure 2. (A–C, G, H, J, and K) Details of explants. Full lateral views are shown below. Arrowheads mark invading ENCs. (A and D) BMP2 treatment of WT ventricular explants induces invasive EMT, increasing 2D and 3D TI (P = 2 × 10–4 and 2.7 × 10–4). (B and E) BMP2 treatment increases the 3D TI of Tie2-Cre;N1ICD explants (P = 9 × 10–4) at the expense of reduced 2D TI. (C and D) Anti–TGF-β2 reduces the 2D and 3D TI of BMP2-treated WT explants (P = 4.1 × 10–3 and 1.8 × 10–7). (F) BMP2-treated WT ventricular explants upregulate Snail1, Has2, and Periostin, but Twist1 appears unaffected. (G–I) Inhibition of Notch with DAPT reduces invasive capacity (3D TI) of BMP2-treated WT ventricular explants (P = 1.02 × 10–8), while increasing 2D TI (P = 1.3 × 10–4). (J–L) Lentiviral-mediated shRNA Snail1 downregulation reduces the invasive capacity of BMP2-treated WT explants. (P = 3.4 × 10–2). m, myocardium. Scale bar: 50 μm. Results are expressed as mean + SD. **P < 0.01; ***P < 0.001.
Anti–TGF-β2 antibody inhibited the effect of BMP2 on WT explants (Figure 3, C and D), indicating that, as in AVC EMT, TGF-β2 acts downstream of Bmp2 during ventricular EMT. Although Bmp6 was ectopically expressed in Tie2-Cre;N1ICD ventricular endocardium (Supplemental Table 1 and Supplemental Figure 4, E, F, and I), BMP6 did not induce EMT in WT ventricular explants (not shown).
To examine the requirement for Notch in BMP2-induced ventricular EMT, we cultured WT ventricular explants with BMP2 plus the γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT) (41). DAPT reduced invasion after 72 hours, increasing 2D TI while reducing 3D TI (Figure 3, G–I). Thus, inhibition of Notch in BMP2-treated WT ventricular explants led to accumulation of scattered cells that did not invade. BMP2-induced invasion and 3D TI were similarly reduced in WT ventricular explants transduced with Snail1-shRNA (Figure 3, J–L). Thus, Tgf-β2, Notch, and Snail1 participate in the molecular mechanism underlying BMP2-induced invasive EMT in ventricular explants.
Myocardial-specific Notch1 activation leads to Bmp2 and Tgfb2 repression and ectopic Snail1 expression. Studies in chick and mouse have shown that Hey transcription factors repress Bmp2 expression in chamber myocardium, restricting it to AVC and OFT territory (42, 43). To determine whether myocardially expressed N1ICD impaired endocardial EMT via Hey-mediated Bmp2 repression, we used the Nkx2.5-Cre driver line, which is active in both endocardium and myocardium from E7.5 (44). Supplemental Figure 8A shows Cre reporter activity in these tissues at E9.5. N1ICD-GFP was expressed throughout the heart of Nkx2.5-Cre;N1ICD embryos (Supplemental Figure 8B). At E9.5, Nkx2.5-Cre;N1ICD embryos showed pericardial distension and heart dilation, with poorly defined boundaries between chamber and nonchamber tissue, an AVC region devoid of transformed cells, and a thin ventricular myocardium with underdeveloped trabeculae (Supplemental Figure 8, C–G). Hey1 was expressed throughout the myocardium and endocardium, including the AVC (Figure 4, A and B). The expanded Hey1 domain was reflected in increased transcription by RT-PCR (Figure 4P). Myocardial Hey2 and Heyl expression was unaltered (not shown), but was increased overall (Figure 4P and data not shown) due to stronger endocardial expression.
Myocardial Notch1 activation leads to loss of AVC identity. (A–O) WISH of E9.5 hearts, showing detail of AVC and LV. Brackets mark the AVC. Arrowheads, myocardium; arrows, endocardium. la, left atrium; ra, right atrium. (A–C) Hey1. Expression is restricted to atrial myocardium and endocardium in WT hearts, extends throughout myocardium and endocardium of Nkx2.5-Cre;N1ICD hearts (B) and throughout the myocardium of cTnT-Cre;N1ICD hearts (C). (D–F) Bmp2 expression in WT AVC is markedly reduced in transgenic hearts. (G–I) Tgfb2. Expression in WT AVC is reduced in transgenic hearts. (J–L) Anf is restricted to WT atrium and ventricle myocardium, and is extended to AVC myocardium in transgenic hearts. (M–O) Snail1 is expressed in WT AVC endocardium and mesenchyme (M) and extends throughout the myocardium and endocardium of Nkx2.5-Cre;N1ICD hearts (N) and throughout the myocardium of cTnT-Cre;N1ICD hearts (O). Scale bar: 30 μm. (P and Q) RT-PCR of E9.5 WT and Nkx2.5-Cre;N1ICD hearts (P) and cTnT-Cre;N1ICD hearts (Q).
The ectopic Hey1 expression was accompanied by reduced Bmp2 in Nkx2.5-Cre;N1ICD AVC myocardium (Figure 4, D, E, and P). Tgfb2 transcription in AVC myocardium (Figure 4G) was strongly reduced in transgenic embryos (Figure 4, H and P). Expression of the myocardial chamber marker Anf was expanded to the AVC (Figure 4, J, K, and P), suggesting that AVC identity was lost in myocardial cells. Snail1 was exclusively expressed in AVC and OFT endocardium and mesenchyme of WT embryos (Figure 4M), while Snail1 transcript and protein were ectopically expressed throughout the endocardium and myocardium of Nkx2.5-Cre;N1ICD embryos (Figure 4N and data not shown).
To substantiate these findings, Notch1 was activated exclusively in the myocardium by breeding into the cTnT-Cre line, which is active in every heart segment from E7.5 onwards (45). Supplemental Figure 8H shows myocardial Cre reporter activity at E9.5. cTnT-Cre;N1ICD embryos expressed N1ICD-GFP throughout the myocardium (Supplemental Figure 8I). E10.5 transgenic embryos were smaller than WT and showed pericardial distension, poorly defined cardiac regions, and a lack of mesenchymal cells in the AVC (Supplemental Figure 8, J–M). Trabeculae were apparent (Supplemental Figure 8, L and N) but slightly delayed compared with WT embryos (Supplemental Figure 1, B and F). Hey1 was expressed throughout the myocardium of cTnT-Cre;N1ICD embryos, including the AVC (Figure 4C and data not shown), and was increased (Figure 4Q). Bmp2 and Tgfb2 expression were reduced (Figure 4, F, I, and Q), and as in Nkx2.5-Cre;N1ICD embryos, Anf expression was extended to AVC myocardium (Figure 4, L and Q), suggesting loss of AVC identity. Likewise, Snail1 was abnormally expressed in the myocardium (Figure 4O) and increased (Figure 4Q).
The aberrant Hey1 and Bmp2 expression in the myocardium of Nkx2.5-Cre;N1ICD and cTnT-Cre;N1ICD embryos supports the idea that N1ICD-driven ectopic Hey1 expression represses Bmp2 in AVC myocardium. Hey and Bmp2 expression were examined in Notch loss of function (LOF) (Supplemental Figure 9). The expression of Hey1 and Hey2 was detected in chamber myocardium (Supplemental Figure 9, A and C). Hey1 was also found in atrial endocardium (Supplemental Figure 9A), Hey2 throughout the endocardium (Supplemental Figure 9C), and Heyl in AVC endocardium (Supplemental Figure 9E). In RBPJk mutants, myocardial Hey1 and Hey2 expression were unaffected (Supplemental Figure 9, B and D), whereas endocardial Hey gene expression was reduced (Supplemental Figure 9, B, D, F, and I). In RBPJk mutants (Supplemental Figure 9, G and H), Bmp2 expression was not affected in the myocardium but was upregulated in the endocardium (Supplemental Figure 9, H and I). These data suggest that Hey2 acts downstream of Notch in repressing Bmp2 expression in the endocardium.
Ectopic myocardial Notch1 activity impairs EMT in a Bmp2-dependent fashion. To study the effect of deregulated Bmp2 and Snail1 expression on EMT, we performed cardiac explant experiments with E9.5 Nkx2.5-Cre;N1ICD and cTnT-Cre;N1ICD embryos. As expected, WT ventricular endocardium grew as a monolayer (Figure 5A) with a few scattered ENCs at the explant edge and almost no invasion (Figure 5J). WT AVC explants showed ENC outgrowth and several invading mesenchymal cells (Figure 5B), with 2D and 3D TI between 0.1 and 0.15 (Figure 5K). Addition of BMP2 significantly increased surface migration and invasion (Figure 5C and Supplemental Video 3), reflected in 2D and 3D TI values of greater than 0.3 and greater than 0.2 (Figure 5K).
BMP2 treatment rescues EMT in Notch1-expressing myocardium. Heart explants triple stained as in Figure 2. (A–I) Details of explants. Full lateral views are shown below. (A) WT ventricular explants show an endocardial monolayer. (B and C) WT AVC explants ± BMP2 undergo EMT. (D) In Nkx2.5-Cre;N1ICD ventricular explants, ENCs migrate across the collagen surface, but are not invasive. (E) Nkx2.5-Cre;N1ICD AVC explants produce migratory mesenchymal cells that show reduced invasion, which is rescued by BMP2 (F). (G) In cTnT-Cre;N1ICD ventricular explants, most ENCs grow as a monolayer and are noninvasive. (H) Mesenchymal cells in cTnT-Cre;N1ICD AVC explants migrate but show reduced invasion, which is rescued by BMP2 (I). Arrows, ENCs; arrowheads, invasive mesenchymal cells. (J) TI analysis of ventricular explants. Most ENCs in Nkx2.5-Cre;N1ICD explants (Nkx) migrate over the gel surface (P = 2.2 × 10–7 for 2D TI versus WT explants), whereas few cells in cTnT-Cre;N1ICD explants (abbreviated cTnT) migrate in 2D. 3D TI is very low for both genotypes. (K) TI analysis of AVC explants. BMP2 treatment of WT explants significantly increases 2D and 3D TI (P = 3.7 × 10–2 and 6.1 × 10–3). Nkx2.5-Cre;N1ICD explants (Nkx) show increased 2D TI (P = 3.5 × 10–4) but a markedly reduced 3D TI compared with WT (P = 5.7 × 10–3). BMP2 treatment increases Nkx2.5-Cre;N1ICD 3D TI (P = 6.7 × 10–4) and slightly reduced 2D TI. BMP2 treatment sharply increases the 3D TI of cTnT-Cre;N1ICD explants (cTnT; P = 1.9 × 10–3). m, myocardium. Scale bar: 50 μm. Results are expressed as mean + SD. *P < 0.005; **P < 0.01; ***P < 0.001.
Ventricular explants of Nkx2.5-Cre;N1ICD embryos generated scattered, noninvasive ENCs (Figure 5D) with a 2D TI (0.9) significantly higher than that of WT explants (Figure 5J). Nkx2.5-Cre;N1ICD AVC explants (Figure 5E and Supplemental Video 4) showed relatively high surface migration (2D TI = 0.4; Figure 5K) but severely reduced invasion (3D TI < 0.1; Figure 5K). Addition of BMP2 restored the WT phenotype (3D TI = 0.2; Figure 5, F and K, and Supplemental Video 4).
cTnT-Cre;N1ICD ventricular explants behaved similarly to WT ventricular explants, with no endocardial transformation (Figure 5, G and J), consistent with the lack of ectopically activated endocardial Notch1 in this model. cTnT-Cre;N1ICD AVC explants (Figure 5H) transformed very poorly (3D TI < 0.1; Figure 5K), but addition of BMP2 restored invasiveness (3D TI = 0.3; Figure 5, I and K).
These data indicate that Notch1 activation in endocardium endows chamber ENCs with transforming ability. Notch1 activation in myocardium leads to Bmp2 and Tgfb2 downregulation by ectopic Hey1 expression.
Bmp2 promotes Snail1 expression and stability, and its inactivation impairs Notch1 signaling in AVC. During EMT, SNAIL1 is regulated by 2 sequential GSK3β-mediated phosphorylation events. The first SNAIL1 phosphorylation event induces nuclear export; the second, proteasomal degradation (46). In endothelial cells, Bmp2 induces ERK1/2 phosphorylation (activation), which itself phosphorylates (inactivates) GSK3β (47). We tested the putative link among Bmp2 signaling, Gsk3β inhibition, and Snail1 stabilization in ENCs. Immunoblotting of bovine aortic endothelial cells (BAECs) incubated with the proteasome inhibitor MG132 (46) detected a 31-kDa Snail1 band, while the levels of p-Gsk3β and p-Erk1/2 were low (Figure 6A). Addition of BMP2 markedly increased Snail1 expression as well as the levels of p-Gsk3β and p-Erk1/2, while the total amount of Gsk3β was unaffected (Figure 6A). Immunofluorescence of unstimulated BAECs detected weak nuclear Snail1 expression (Figure 6, B and C) and faint, predominantly perinuclear staining of p-Gsk3β (Figure 6, D and E). In BMP2-treated BAECs, Snail1 nuclear staining was increased (120% increase) and perinuclear p-Gsk3β staining was also stronger (80%; Figure 6, G–J).
BMP2 inhibits Gsk3β, leading to Snail1 expression and nuclear stabilization. Deletion of myocardial Bmp2 reduces Notch1 signaling in AVC. (A) Immunoblot of BAECs cultured ± BMP2. Weak Snail1 expression is detected in the absence of BMP2. BMP2 induces increased Snail1 levels and increases phosphorylation of Gsk3β and Erk1/2, suggesting Gsk3β inhibition. (B–I) Immunostaining of BAECs cultured ± BMP2. (B and F) DAPI-counterstained nuclei. (C and G) Snail1 expression; nuclear staining in BMP2-treated cells is stronger and more punctate. (D and H) p-Gsk3β; predominant perinuclear p-Gsk3β staining is stronger after BMP2 treatment. (E and I) Merged showing DAPI, Snail1, and p-Gsk3β staining. (J) Quantification of Snail1 and p-Gsk3β protein. Expression is increased upon BMP2 treatment. (K) RT-PCR analysis of Snail1 expression in BAECs cultured ± BMP2 and ± NF-κB inhibitor. Snail1 expression is reduced in the presence of BMP2 and NF-κB inhibitor. (L) RT-PCR of E10.5 WT and cTnT-Cre;Bmp2flox hearts. Notch1 and Snail1 expression is reduced in mutant hearts. (M–R) N1ICD immunostaining (green). Nuclei are DAPI counterstained (blue). (M–O) E10 WT heart. (P–R) cTnT-Cre;Bmp2flox heart. (M and P) General views. (N and Q) AVC detail. Arrows mark N1ICD-positive nuclei in WT AVC endocardium (N) and weakly positive nuclei in the corresponding region of the mutant (Q). (O and R) Detail of LV. Arrows mark N1ICD-positive nuclei in endocardium at the base of trabeculae in WT (O) and mutant embryos (R). Scale bars: 20 μm. Results are expressed as mean + SD. ***P < 0.001.
In epithelial cells, Gsk3β has also been shown to regulate Snail1 at the transcriptional level, together with Gsk3α, via NF-κB inhibition (48). We tested to determine whether this mechanism contributes to the effect of BMP2 in BAECs. Figure 6K shows that adding BMP2 to BAECs markedly increased Snail1 mRNA while BMP2 plus an NF-κB inhibitor markedly reduced it. We tested the effect of NF-κB inhibition on the BMP2-driven EMT of ventricular explants. WT ventricular explants cultured with BMP2 underwent invasive EMT (Supplemental Figure 10, A and C), which was notably reduced when an NF-κB inhibitor was added to the culture medium (Supplemental Figure 10, B and C). This effect was also reflected by the marked reduction of Snail1 mRNA upon addition of the NF-κB inhibitor (Supplemental Figure 10D). Together these observations suggest that BMP2 treatment of endothelial cells augments Snail1 mRNA in an NF-κB–dependent manner and stabilizes Snail1 protein by Gsk3β phosphorylation/ inactivation.
Our data show that Bmp2 and Notch1 cooperate to induce invasive EMT in ventricular explants. This process is Notch dependent, and the noninvasive phenotype of AVC explants ectopically expressing Notch1 in the myocardium is rescued by exogenous BMP2. To explore the Bmp2-Notch1 relationship in vivo, we crossed a conditional Bmp2 mutant (49) with the myocardial-specific cTnT-Cre driver line. E10.5 cTnT-Cre;Bmp2flox embryos lacked defined AVC and EC tissue (Supplemental Figure 11, A–F), similar to the phenotype obtained with the Nkx2.5-Cre driver (10, 11). Cardiac expression of Notch1 (and Snail1) was markedly reduced (Figure 6L), which, given the exclusive endocardial Notch1 expression at this stage, suggests that myocardial Bmp2 deletion impairs endocardial Notch1 expression. In E10 WT embryos, N1ICD is localized in most ENCs in the AVC and to ENCs at the base of trabeculae in the ventricles (Figure 6, M–O, and ref. 14). In cTnT-Cre;Bmp2flox mutants, N1ICD staining was strongly reduced in AVC endocardium (Figure 6, P and Q) but ventricular staining was unaffected (Figure 6, P and R). These data suggest that Bmp2 deletion in the myocardium specifically impairs Notch1 expression and activity in AVC endocardium.